Prashant Kohli
Chief Executive Officer en ACASTI PHARMA INC. .
Fortuna: 73 148 $ al 31/03/2024
Perfil
Prashant Kohli is currently the Chief Executive Officer & Director at Acasti Pharma, Inc. He previously worked as the Vice President-Commercial Operations at Grace Therapeutics LLC.
Mr. Kohli completed his undergraduate degree at Augustana College (Illinois) and holds undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
06/05/2024 | 21 357 ( 0.23% ) | 73 148 $ | 31/03/2024 |
Cargos activos de Prashant Kohli
Empresas | Cargo | Inicio |
---|---|---|
ACASTI PHARMA INC. | Chief Executive Officer | 04/04/2023 |
Antiguos cargos conocidos de Prashant Kohli.
Empresas | Cargo | Fin |
---|---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Corporate Officer/Principal | 01/08/2021 |
Formación de Prashant Kohli.
Augustana College (Illinois) | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Prashant Kohli